Cargando…

Clinical characterization and the mutation spectrum in Swedish adenomatous polyposis families

BACKGROUND: The dominantly inherited condition familial adenomatous polyposis (FAP) is caused by germline mutations in the APC gene. Finding the causative mutations has great implications for the families. Correlating the genotypes to the phenotypes could help to improve the diagnosis and follow-up...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanter-Smoler, Gunilla, Fritzell, Kaisa, Rohlin, Anna, Engwall, Yvonne, Hallberg, Birgitta, Bergman, Annika, Meuller, Johan, Grönberg, Henrik, Karlsson, Per, Björk, Jan, Nordling, Margareta
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2386495/
https://www.ncbi.nlm.nih.gov/pubmed/18433509
http://dx.doi.org/10.1186/1741-7015-6-10
_version_ 1782155245376241664
author Kanter-Smoler, Gunilla
Fritzell, Kaisa
Rohlin, Anna
Engwall, Yvonne
Hallberg, Birgitta
Bergman, Annika
Meuller, Johan
Grönberg, Henrik
Karlsson, Per
Björk, Jan
Nordling, Margareta
author_facet Kanter-Smoler, Gunilla
Fritzell, Kaisa
Rohlin, Anna
Engwall, Yvonne
Hallberg, Birgitta
Bergman, Annika
Meuller, Johan
Grönberg, Henrik
Karlsson, Per
Björk, Jan
Nordling, Margareta
author_sort Kanter-Smoler, Gunilla
collection PubMed
description BACKGROUND: The dominantly inherited condition familial adenomatous polyposis (FAP) is caused by germline mutations in the APC gene. Finding the causative mutations has great implications for the families. Correlating the genotypes to the phenotypes could help to improve the diagnosis and follow-up of patients. METHODS: Mutation screening of APC and the clinical characterization of 96 unrelated FAP patients from the Swedish Polyposis Registry was performed. In addition to generally used mutation screening methods, analyses of splicing-affecting mutations and investigations of the presence of low-frequency mutation alleles, indicating mosaics, have been performed, as well as quantitative real-time polymerase chain reaction to detect lowered expression of APC. RESULTS: Sixty-one different APC mutations in 81 of the 96 families were identified and 27 of those are novel. We have previously shown that 6 of the 96 patients carried biallelic MUTYH mutations. The 9 mutation-negative cases all display an attenuated or atypical phenotype. Probands with a genotype (codon 1250–1464) predicting a severe phenotype had a median age at diagnosis of 21.8 (range, 11–49) years compared with 34.4 (range, 14–57) years among those with mutations outside this region (P < 0.017). Dense polyposis (> 1000) occurred in 75% of the probands with a severe phenotype compared with 30% in those with mutations outside this region. The morbidity in colorectal cancer among probands was 25% at a mean age of 37.5 years and 29% at a mean age of 46.6 years. CONCLUSION: Using a variety of mutation-detection techniques, we have achieved a 100% detection frequency in classical FAP. Probands with APC mutations outside codon 1250–1464, although exhibiting a less-severe phenotype, are at high risk of having a colorectal cancer at diagnosis indicating that age at diagnosis is as important as the severity of the disease for colorectal cancer morbidity.
format Text
id pubmed-2386495
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-23864952008-05-16 Clinical characterization and the mutation spectrum in Swedish adenomatous polyposis families Kanter-Smoler, Gunilla Fritzell, Kaisa Rohlin, Anna Engwall, Yvonne Hallberg, Birgitta Bergman, Annika Meuller, Johan Grönberg, Henrik Karlsson, Per Björk, Jan Nordling, Margareta BMC Med Research Article BACKGROUND: The dominantly inherited condition familial adenomatous polyposis (FAP) is caused by germline mutations in the APC gene. Finding the causative mutations has great implications for the families. Correlating the genotypes to the phenotypes could help to improve the diagnosis and follow-up of patients. METHODS: Mutation screening of APC and the clinical characterization of 96 unrelated FAP patients from the Swedish Polyposis Registry was performed. In addition to generally used mutation screening methods, analyses of splicing-affecting mutations and investigations of the presence of low-frequency mutation alleles, indicating mosaics, have been performed, as well as quantitative real-time polymerase chain reaction to detect lowered expression of APC. RESULTS: Sixty-one different APC mutations in 81 of the 96 families were identified and 27 of those are novel. We have previously shown that 6 of the 96 patients carried biallelic MUTYH mutations. The 9 mutation-negative cases all display an attenuated or atypical phenotype. Probands with a genotype (codon 1250–1464) predicting a severe phenotype had a median age at diagnosis of 21.8 (range, 11–49) years compared with 34.4 (range, 14–57) years among those with mutations outside this region (P < 0.017). Dense polyposis (> 1000) occurred in 75% of the probands with a severe phenotype compared with 30% in those with mutations outside this region. The morbidity in colorectal cancer among probands was 25% at a mean age of 37.5 years and 29% at a mean age of 46.6 years. CONCLUSION: Using a variety of mutation-detection techniques, we have achieved a 100% detection frequency in classical FAP. Probands with APC mutations outside codon 1250–1464, although exhibiting a less-severe phenotype, are at high risk of having a colorectal cancer at diagnosis indicating that age at diagnosis is as important as the severity of the disease for colorectal cancer morbidity. BioMed Central 2008-04-24 /pmc/articles/PMC2386495/ /pubmed/18433509 http://dx.doi.org/10.1186/1741-7015-6-10 Text en Copyright © 2008 Kanter-Smoler et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Kanter-Smoler, Gunilla
Fritzell, Kaisa
Rohlin, Anna
Engwall, Yvonne
Hallberg, Birgitta
Bergman, Annika
Meuller, Johan
Grönberg, Henrik
Karlsson, Per
Björk, Jan
Nordling, Margareta
Clinical characterization and the mutation spectrum in Swedish adenomatous polyposis families
title Clinical characterization and the mutation spectrum in Swedish adenomatous polyposis families
title_full Clinical characterization and the mutation spectrum in Swedish adenomatous polyposis families
title_fullStr Clinical characterization and the mutation spectrum in Swedish adenomatous polyposis families
title_full_unstemmed Clinical characterization and the mutation spectrum in Swedish adenomatous polyposis families
title_short Clinical characterization and the mutation spectrum in Swedish adenomatous polyposis families
title_sort clinical characterization and the mutation spectrum in swedish adenomatous polyposis families
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2386495/
https://www.ncbi.nlm.nih.gov/pubmed/18433509
http://dx.doi.org/10.1186/1741-7015-6-10
work_keys_str_mv AT kantersmolergunilla clinicalcharacterizationandthemutationspectruminswedishadenomatouspolyposisfamilies
AT fritzellkaisa clinicalcharacterizationandthemutationspectruminswedishadenomatouspolyposisfamilies
AT rohlinanna clinicalcharacterizationandthemutationspectruminswedishadenomatouspolyposisfamilies
AT engwallyvonne clinicalcharacterizationandthemutationspectruminswedishadenomatouspolyposisfamilies
AT hallbergbirgitta clinicalcharacterizationandthemutationspectruminswedishadenomatouspolyposisfamilies
AT bergmanannika clinicalcharacterizationandthemutationspectruminswedishadenomatouspolyposisfamilies
AT meullerjohan clinicalcharacterizationandthemutationspectruminswedishadenomatouspolyposisfamilies
AT gronberghenrik clinicalcharacterizationandthemutationspectruminswedishadenomatouspolyposisfamilies
AT karlssonper clinicalcharacterizationandthemutationspectruminswedishadenomatouspolyposisfamilies
AT bjorkjan clinicalcharacterizationandthemutationspectruminswedishadenomatouspolyposisfamilies
AT nordlingmargareta clinicalcharacterizationandthemutationspectruminswedishadenomatouspolyposisfamilies